- ►adisonline.com [PDF] F Garcia-Bournissen, DS Feig, G Koren - Clinical pharmacokinetics, 2003 - ingentaconnect.com Abstract Due to legal, ethical and monetary problems, drug studies in pregnancy are rare. Numerous
pharmacokinetic and pharmacodynamic changes occur in preg- nancy that can affect the efficacy
and safety of drugs, and these are difficult to predict without appropriate studies. Drugs ... Cited by 38 - Related articles - BL Direct - All 6 versions
MW CARPENTER - Diabetes in women: adolescence, pregnancy, …, 2004 - books.google.com TESTING FOR GESTATIONAL DIABETES MARSHALL W. CARPENTER The association between
type 2, non-insulin-dependent diabetes mellitus and a prior history of large babies, still-
births, or neonatal deaths has been observed for several decades (1). The inference that ... Cited by 15 - Related articles - All 2 versions
G Tamás, Z Kerényi - Current Diabetes Reports, 2002 - Springer Introduction According to the present widely accepted description, ges- tational diabetes mellitus
(GDM) is defined as “any degree of glucose intolerance with onset or first recognition dur- ing
pregnancy.” This definition incorporates a huge variety of carbohydrate metabolic ... Cited by 13 - Related articles - All 2 versions
- ►diabetesjournals.org SL Kjos, UM Schaefer-Graf - Diabetes care, 2007 - Am Diabetes Assoc The traditional treatment goal for gestational diabetes mellitus (GDM) has been to achieve
“normal” range values for maternal glucose by diet and or insulin therapy, adapting a strategy
successful in treating pregestational diabetes during pregnancy. Intensive insulin therapy ... Cited by 5 - Related articles - BL Direct - All 6 versions
- ►yimg.com [PDF] EA Reece, G Leguizamón, A Wiznitzer - The Lancet, 2009 - Elsevier Gestational diabetes mellitus is a substantial and growing health concern in many parts of the
world. Certain populations are especially vulnerable to developing this condition because of
genetic, social, and environmental factors. Gestational diabetes has serious, long-term ... Cited by 7 - Related articles - All 38 versions
RDAGB Maria, LCA De Vivoa, ADBF … - Gynecol Obstet Invest, 2007 - content.karger.com Leptin is a 167-amino-acid polypeptide hormone which was initially identified as an
adipocyte-derived hormone [1] . This product of the obese (ob) gene is a modulator of feeding
behavior and adipose stores [2] . Maternal serum leptin levels increase throughout the ... Cited by 3 - Related articles - BL Direct - All 5 versions
H Leipold, C Worda, A Ozbal, P Husslein, E … - Reproductive …, 2005 - rsx.sagepub.com Page 1. http://rsx.sagepub.com Investigation Journal of the Society for Gynecologic
DOI: 10.1016/j.jsgi.2005.05.003 2005; 12; 529 Journal of the Society for Gynecologic
Investigation Heinz Leipold, Christof Worda, Aral Özbal ... Cited by 1 - Related articles - All 4 versions
MM Taslimi, K Navabi, R Acosta, A Helmer, YY … - Journal of Diabetes …, 2008 - journalofdst.org Masoud Mark Taslimi, MD,1 Kasra Navabi, MD,2 Reinaldo Acosta, MD,3 Amy Helmer, MD,1
and Yasser Y. El-Sayed, MD1 ... Author Affiliations: 1Department of Obstetrics and
Gynecology, Stanford University, Stanford, California; 2Medical-Legal Consultants, LLC, ... Related articles - View as HTML - All 2 versions
C Klieger, E Pollex, A Kazmin, G … - Therapeutic Drug …, 2009 - pdfs.journals.lww.com Abstract: A wide range of physiological and hormonal changes occur during pregnancy. Most
begin early in the first trimester and increase by the last trimester. These changes can significantly
affect pharmacokinetics and pharmacodynamics of drugs and thus may alter their safety ... Related articles - All 6 versions
C Zagreb - Diabetologia Croatica, 2004 - idb.hr Women at high risk of gestational diabetes are those with marked obesity, personal history of
gestational diabetes mellitus, glycosuria, or a strong family history of diabetes. Women at low
risk of gestational diabetes are those at the age below 25, normal body weight before ... Related articles
